Company intelligence / Profile preview

Melcare Biomedical

Mt Cotton, Queensland, AUSmelcare.com ↗

Ownership: Private
Development stage: Other

Overview

Melcare Biomedical has commercialized several over-the-counter and clinician-prescribed products using pharmaceutical-grade Manuka honey. Their Optimel line for dry eye has demonstrated significant reduction in symptom severity compared to conventional lubricants. The company’s wound gels and nasal sprays are also available commercially in Australia, Europe, and expanding into the US market.

Therapeutic areas: DermatologyOphthalmologyInfectious Diseases
Modalities: Biologic (specifically, medical grade honey-based products)Device (for wound care and eye care applications)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Melcare Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melcare Biomedical.

Explore the full profile